NLS Pharma is a clinical-stage drug development company. Our R&D Focus is based on a strong scientific understanding of neurobehavioral and neurocognitive disorders and their pharmacognosia. Our patient-centered approach increases the rate for success and our successful collaboration with experts across industry, academia allows for a target specific and customized approach.
| Website | http://www.nls-pharma.com |
| Ticker | NLSP |
| Revenue | $34.2 million |
| Employees | 6 (0 on RocketReach) |
| Founded | 2015 |
| Address | 6 The Cir, Zurich, Zurich 8058, CH |
| Phone | +41 41 618 80 00 |
| Fax | +41 41 618 80 09 |
| Industry | Pharmaceuticals, Management Consulting, Biopharma, Healthcare, Biotechnology, Health Care, Science and Engineering, Medical, Pharmaceutical |
| Keywords | Drug Development, Clinical Stage, Neurocognitive Disorders, Pharmacognosy, Research And Development, Pharmaceutical Research, Biopharmaceutical, Drug Discovery, Clinical Trials, Patient Centered, Therapeutics, Neurology, Cognitive Impairment, Behavioral Disorders, Medicine, Biotechnology, Pharma, Healthcare, Science |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Pfizer, GSK, AstraZeneca, Bristol Myers Squibb, Teva Pharmaceuticals, Lilly India +43 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 80 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular NLS Pharma AG employee's phone or email?
NLS Pharma AG Questions
The NLS Pharma AG annual revenue was $34.2 million in 2026.
NLS Pharma AG is based in Zurich, Zurich.
The NAICS codes for NLS Pharma AG are [3254, 325, 32].
The SIC codes for NLS Pharma AG are [283, 80, 28].
Related Companies
